SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-17-001747
Filing Date
2017-03-24
Accepted
2017-03-24 16:19:43
Documents
65
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_032417p.htm 10-K 1258909
2 EXHIBIT 21.1 exh_211.htm EX-21.1 1588
3 EXHIBIT 23.1 exh_231.htm EX-23.1 1936
4 EXHIBIT 31.1 exh_311.htm EX-31.1 8011
5 EXHIBIT 31.2 exh_312.htm EX-31.2 8127
6 EXHIBIT 32.1 exh_321.htm EX-32.1 5008
  Complete submission text file 0001171843-17-001747.txt   5105799

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE mgen-20161231.xml EX-101.INS 695457
8 XBRL SCHEMA FILE mgen-20161231.xsd EX-101.SCH 51085
9 XBRL CALCULATION FILE mgen-20161231_cal.xml EX-101.CAL 38311
10 XBRL DEFINITION FILE mgen-20161231_def.xml EX-101.DEF 456490
11 XBRL LABEL FILE mgen-20161231_lab.xml EX-101.LAB 352729
12 XBRL PRESENTATION FILE mgen-20161231_pre.xml EX-101.PRE 469286
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36483 | Film No.: 17712996
SIC: 8071 Services-Medical Laboratories